These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10586025)

  • 1. Targeting of human dendritic cells by autologous NK cells.
    Wilson JL; Heffler LC; Charo J; Scheynius A; Bejarano MT; Ljunggren HG
    J Immunol; 1999 Dec; 163(12):6365-70. PubMed ID: 10586025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of Qa1b in the protection of mature dendritic cells from NK cell-mediated killing.
    Persson CM; Assarsson E; Vahlne G; Brodin P; Chambers BJ
    Scand J Immunol; 2008 Jan; 67(1):30-6. PubMed ID: 18028286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of NK- or NK-CTL-mediated lysis of immature or mature autologous dendritic cells.
    Pietra G; Romagnani C; Mazzarino P; Millo E; Moretta L; Mingari MC
    Eur J Immunol; 2003 Dec; 33(12):3427-32. PubMed ID: 14635052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of tumor-dendritic cell fusion vaccines on the cytotoxicity of CIK/NK cells from cord blood].
    Li Y; Huang SL; Wu YF; Wei J; Meng Y; Zhou DH; Bao R
    Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):269-72. PubMed ID: 15949286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells.
    Ferlazzo G; Morandi B; D'Agostino A; Meazza R; Melioli G; Moretta A; Moretta L
    Eur J Immunol; 2003 Feb; 33(2):306-13. PubMed ID: 12548561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell function in HIV-1 infected patients.
    Fortis C; Tasca S; Capiluppi B; Tambussi G
    J Biol Regul Homeost Agents; 2002; 16(1):30-2. PubMed ID: 12003170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood dendritic cells, but not monocyte-derived dendritic cells, can augment human NK cell function.
    Osada T; Nagawa H; Kitayama J; Tsuno NH; Ishihara S; Takamizawa M; Shibata Y
    Cell Immunol; 2001 Oct; 213(1):14-23. PubMed ID: 11747352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer dendritic cells are an intermediate of developing dendritic cells.
    Chen L; Calomeni E; Wen J; Ozato K; Shen R; Gao JX
    J Leukoc Biol; 2007 Jun; 81(6):1422-33. PubMed ID: 17332372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The cytotoxicity of CIK/NK cells stimulated by K562-DC fusion vaccines in NOD/SCID mice model for human erythroleukemia].
    Li Y; Huang SL; Zhang XC; Fang JP; Wu YF; Wei J; Huang WG; Zhou DH; Huang K; Lin YC
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):39-43. PubMed ID: 18512314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC.
    Marcenaro E; Ferranti B; Falco M; Moretta L; Moretta A
    Int Immunol; 2008 Sep; 20(9):1155-67. PubMed ID: 18596023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk.
    Fernandez NC; Flament C; Crépineau F; Angevin E; Vivier E; Zitvogel L
    Eur Cytokine Netw; 2002; 13(1):17-27. PubMed ID: 11956017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes.
    Drillien R; Spehner D; Bohbot A; Hanau D
    Virology; 2000 Mar; 268(2):471-81. PubMed ID: 10704355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cells at the interface between innate and adaptive immunity.
    Moretta A; Marcenaro E; Parolini S; Ferlazzo G; Moretta L
    Cell Death Differ; 2008 Feb; 15(2):226-33. PubMed ID: 17541426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
    Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
    Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NKp30.
    Balsamo M; Zambello R; Teramo A; Pedrazzi M; Sparatore B; Scordamaglia F; Pende D; Mingari MC; Moretta L; Moretta A; Semenzato G; Vitale M
    Exp Hematol; 2009 Oct; 37(10):1167-75. PubMed ID: 19580844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells.
    Gros F; Cabillic F; Toutirais O; Maux AL; Sebti Y; Amiot L
    Eur J Immunol; 2008 Mar; 38(3):742-9. PubMed ID: 18266268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cells recognize and kill human glioblastoma cells with stem cell-like properties.
    Castriconi R; Daga A; Dondero A; Zona G; Poliani PL; Melotti A; Griffero F; Marubbi D; Spaziante R; Bellora F; Moretta L; Moretta A; Corte G; Bottino C
    J Immunol; 2009 Mar; 182(6):3530-9. PubMed ID: 19265131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.